CDKN2C and breast cancer: We then followed mammary tumors and found that p18-/- tumors were well-differentiated tumors most of which were positive for GATA3 and E-Cad, a downstream target of GATA3, but p18-/- tumors were negative or weakly expressing Vim and EMT-TFs which include TWIST and FRA1.